Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeBiotech

      Biotech

      Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X
      Biotech

      Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X

      August 5, 2026
      Grace Therapeutics Announces $10 Million Private Placement
      Biotech

      Grace Therapeutics Announces $10 Million Private Placement

      August 5, 2026
      IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
      Biotech

      IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

      August 4, 2026
      SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies
      Biotech

      SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

      August 4, 2026
      Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
      Biotech

      Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference

      August 4, 2026
      CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)
      Biotech

      CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)

      August 4, 2026
      Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
      Biotech

      Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

      August 4, 2026
      Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
      Biotech

      Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference

      August 4, 2026
      XORTX Announces Director Resignation
      Biotech

      XORTX Announces Director Resignation

      August 1, 2026
      Profusa Announces Signing of Option Agreement for the  Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
      Biotech

      Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs

      August 1, 2026
      « 1 … 13 14 15 16 17 … 212 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026